I would now like to hand the conference over to Mr. Sam Fischer, Managing Director and Chief Executive Officer. Please go ahead. Good morning, and thank you for joining Treasury Wine Estates' 2026 full year results briefing. Joining me on the call today is Justin Pipito, our Interim Chief Financial Officer. As Justin and I, and other members of our team shared with you in some detail at our recent investor day, in FY 2026, we took decisive action to ensure the health of our brands and channels, and commenced our comprehensive ASCENT transformation program focused on reshaping TWE for future success. While this decisive action has impacted financial performance in the short term, I am confident we'll emerge a more focused and financially strong company capable of sustained, attractive returns. You can see this story of these actions reflected throughout today's announcement, including our key messages, which I'll turn to now. FY 2026 EBITS of AUD 492 million was ahead of our guidance, driven by Penfolds performance in the fourth quarter. Statutory NPAT was a loss of AUD 1.1 million, driven by the non-cash impairment of U.S. assets. This includes the additional AUD 558 million impairment relating to U.S. supply chain rebalancing initiatives that we announced on Monday, which has been recognized in the second half. We are reiterating our guidance for FY 2027 EBITS, which are expected to be at least equivalent to FY 2026. Importantly, the underlying performance of our key brands remains strong, with depletions growth continuing for Penfolds, led by China and our Asia markets. In the U.S., depletions returned to growth nationally for the year, despite the impact of California distributor transition in the first half. We progressed our previously announced initiatives to ensure brand and channel health, including action to significantly reduce parallel imports into China. We also progressed with the planned reduction of customer inventory, and we're on track to complete this effort in both China and the U.S. within the two-year timeframe that I communicated last December. Retaining the strength of our capital structure remains a key priority. We reported leverage at 2.8x, and we expect this to be the peak ahead of our return to our target of below two times by the end of FY 2028. We have also made substantial progress with ASCENT. As we shared at our investor day in June, we have a clear vision, and we're taking deliberate actions to focus on where we will win, transform our operating model, and shape a future fit supply chain to make it happen. We are currently finalizing our organizational structure ahead of our transition to a regional operating model on the 1st of October. We are on track to realize our cost savings of AUD 100 million per annum in full by FY 2029, with approximately AUD 40 million to be realized in FY 2027. Our global supply chain transformation has commenced, and processes to divest a number of non-priority brands and assets are underway with a pleasing response to date. As announced in June, we are also undertaking a strategic and operational review of our U.S. business. This process is also underway with advisors appointed to review all available options. The decision to reduce U.S. vintage makes from 2026 reflects the type of clear and decisive actions we will be taking to ensure that we improve shareholder returns from the Americas. That is a high-level summary of the result and our transformation agenda. While I am acutely aware that there is still a lot of work to do, I am pleased with the progress we have made since I joined the business last October, and both transformational transformation and operational momentum has gathered pace throughout the year. Turning now in more detail to our financial performance, which was impacted by a number of factors, including the moderation of category trends, our deliberate initiatives to protect brand and channel health, and the cycling of elevated shipments in the prior period. NSR per case fell 3%, reflecting portfolio mix, and in particular, the impact of our actions to reduce parallel activity and inventory in China. EBITS margin decreased to 19%, driven by the decline in NSR and accompanied by higher costs of doing business. ROCE declined to 7.9%, driven by a decline in EBITS. Pre-material items, net profit after tax was AUD 275 million, and EPS was AUD 0.34 per share. Our dividend program remains suspended. This is a temporary yet important measure as we reprioritize our focus on returning leverage to target. Turning now to divisional performance, where pleasingly momentum has improved in the second half. Penfolds delivered EBITS of AUD 404 million, supported by continued depletions growth in China, in Asia, ex-China, and Australia. However, earnings were moderated by the deliberate reductions we have made in inventory cover and restrictions of shipments contributing to parallel import activity into China. It is terrific to see the continued progress Penfolds is making across its key markets, with first-class brand building and execution continuing to translate into increased consumer awareness and demand for the Penfolds brand. More on this shortly, but I am extremely pleased with how the team is showing up in market to consistently drive this growth. Treasury Americas delivered EBITS of AUD 90 million. The result reflected softer market conditions, disruption arising from the Californian distribution transition in the first half, and cycling the excess of shipments to depletions in the prior period. Despite these challenges, we were pleased to see depletions returning to growth in California in the second half, which supported the return to depletions growth nationally. Underlying brand for our key brands in the U.S. remains strong and ahead of category. Having finalized the transition of distribution away from RNDC in several markets, we now turn our attention to reducing customer inventory levels through FY 2027, targeting completion in the first half of FY 2028. Treasury Collective delivered EBITS of AUD 68 million, which was in line with expectations in Australia and EMEA, with positive momentum behind focus brands and continuing declines in the commercial portfolio. In the U.S., performance was, again, impacted by declines in the premium portfolio, led by 19 Crimes. Turning now in more detail to depletions, which are the clearest view of underlying consumer demand across our portfolio and markets. Importantly, we saw improved momentum for Penfolds and Treasury Americas in the second half. Penfolds continues to achieve strong depletions in China. This is a result of the strength of our brand and encouraging trends in consumer demand. Performance in the fourth quarter relative to prior year, and the benefit of transitioning volumes previously parallel imported into our authorized distribution channels, which contributed approximately half of the depletions growth. Outside of China, depletions remain strong in several markets, including Thailand, Malaysia, and Indonesia. Penfolds is well-known among Chinese communities in these countries, and the wine category continues to develop. We believe there is a substantial long-term growth opportunities for the Penfolds brand in these markets. In Australia, strong execution through Chinese New Year and other key activations drove momentum in independent retail channels. Within Treasury Americas, total U.S. depletions were positive, driven by growth from DAOU, Frank Family Vineyards, and Stags' Leap. While California was impacted by the distribution transition during the first half, the business returned to growth in the second half with strong momentum demonstrating improving execution. The depletions growth was driven by ongoing distribution gains with Frank Family Vineyards, in particular, expanding its reach in the on-premise. In Treasury Collective, Squealing Pig, Pepperjack, and Wynns led the Australian depletions performance, supported by strong execution with key partners in innovation. In the U.K., pricing actions taken to offset higher alcohol duties impacted volumes, while in the U.S., 19 Crimes continued its above-category declines. Declines in the commercial portfolio were also driven by the U.K. Overall, the key takeaway is that depletion trends are strengthening across many of our priority brands and markets, giving us confidence in our core strategy and the underlying health of the business. This makes us well-positioned to return to NSR growth from FY 2028 once we have completed inventory rebalancing. Penfolds continues to strengthen its position as one of the world's most recognized luxury wine brands. Over the course of the year, we increased investment behind activations designed to enhance brand awareness, luxury credentials, and deepen consumer engagement. These initiatives continue to drive demand power growth across our key markets. Our Global Grange campaign is a great example. This has created a halo for the brand as a whole, reinforcing Penfolds' luxury positioning with consumers around the world. At the same time, market-specific activations, such as From Penfolds to the World in Bangkok, demonstrates how we are creating culturally relevant experiences that bring the brand to life. I really want to get across that these initiatives are not simply marketing investments. They not only underpin the sustained strong depletions growth Penfolds is delivering, but they are also building long-term brand equity. As outlined at Investor Day, our portfolio is focused on three pillars, and these represent the most attractive market segments where we have conviction in our right to win. During the year, we continued to strengthen our leadership in our first pillar of luxury red wine. While Penfolds remains central to that ambition, DAOU delivered another year of strong category depletions growth in the U.S. Second, with an elevated focus, we saw encouraging growth in luxury white wine, with depletions accelerating in the Penfolds white wine portfolio led by Yattarna, Bin 51, and Bin 311. This gives us confidence that there will be a very promising future for Penfolds in luxury white wine. Third, we are building an excellent position in modern refreshment. Matua is a clear example of this strategy in action, delivering yet another year of growth in the U.S., both in the core range and in the continued success of Matua Lighter. You can already see some of the benefits of us focusing our attention behind our best opportunities, and there will be more to come as we accelerate our investment behind our power brands and regional heroes in the future. During the year, we also made significant progress against our previously announced brand and channel health initiatives. In China, customer inventory cover reduced by approximately 200,000 cases, approximately halfway towards our previously communicated target, with the rebalancing expected to be completed in FY 2027. Strong depletions in China through the fourth quarter allowed us to finish ahead of expectations on this front, which is very pleasing. We also continued our efforts to minimize parallel import activity in China. Availability of unauthorized product reduced materially during the second half, with recapture into authorized channels on track and reflected in the China depletions, as I mentioned earlier. While they have significantly reduced, we have identified some further sources of unauthorized shipments in recent months and taken corrective action. As I have said previously, managing this will require continued vigilance to ensure it remains under tight control, and we are absolutely committed to staying on top of it. Importantly, our action to date has helped stabilize online pricing, and we are seeing pleasing signs of pricing improvement for key bins in July. In the U.S., customer inventory cover remained stable. We repurchased inventory from RNDC in California and have sold approximately 40% of that back into the market at nil margin. The RNDC transition is now largely complete, with our residual exposure now immaterial at less than 3% of Treasury Americas NSR. Our new distribution partners are performing to expectations in the transitioned markets. We now shift our attention to completing the planned 300,000 case inventory reduction ex California progressively over the next 18 months. We are continuing to make meaningful progress against our four ASCENT priority areas, focused on the bright future we are seeing for TWE as a more focused, market-centered, simpler, and financially strong wine company. I am really pleased with the progress we are making, and I have already touched on a number of these key highlights in today's presentation. We look forward to continuing to provide our investors with regular updates as we progress this journey. I will now hand over to Justin, who will cover the financial results in more detail. Thanks, Sam, and good morning, everyone. Starting first with material items. A post-tax material charge of AUD 1.3 billion was recognized for the full year, which includes AUD 458 million recognized in the second half, relating to initiatives to accelerate the rebalancing of the U.S. supply chain, and a further AUD 100 million impairment of U.S. brands, predominantly DAOU, Frank Family, and Beaulieu Vineyard, recognized as a result of the year-end impairment review process. We are taking proactive steps to address the structural misalignment in the U.S., including, among other things, a reduction in North Coast vintage make sizes from vintage 2026 to rebalance our supply chain. The material item recognized reflects asset impairments from lower future utilization across the network, the write-off of capitalized costs already incurred in vintage 2026, and a write-down of predominantly bulk wine inventory, which will help accelerate sales in the open market. These actions are intended to accelerate an improvement in the Americas region profitability over the medium term. Additional material items include ASCENT-related restructuring and redundancy costs and the RNDC settlement to compensate TWE for the impact of RNDC's closure in California. This amount is net of amounts incurred by TWE to execute the buyback. Note: the cash portion shown includes the buyback of inventory at original sales value, net of the cash realized on resale of the inventory in the second half, which is included in ordinary cash flows in the statement of cash flows. Other items includes the sale of supply chain assets in Australia, write-down of assets held for sale outside of the ASCENT program, and the non-cash half one accounting associated with the contingent DAOU earn-out. Turning to an update on ASCENT one-off costs following the additional U.S. initiatives announced earlier this week. ASCENT will give rise to a number of one-off material items, with the majority of P&L and cash impacts expected to be recognized by FY 2028. Our expected one-time costs remain consistent with what was shared at the investor day. To these costs, we have added the costs associated with the U.S. strategic review announced earlier this week to reflect a revised, updated total expectation for the ASCENT program. On a cash basis, we continue to expect ASCENT to be cash positive on a post-divestment basis. Moving now to the balance sheet. Net assets decreased AUD 1.3 billion on a reported currency basis, with AUD 187 million of this decrease due to foreign currency movements and AUD 1.3 billion due to writedowns associated with the U.S. Excluding these, the key balance sheet movements overall were a decline in payables with reduced vintage intake, a key driver of a reduction, and a reduction in inventory, which I'll talk about more shortly. Net borrowings were broadly unchanged with reduction of interest-bearing debt from cash in the first half. Turning to inventory in more detail. Against the prior corresponding period, total inventory decreased in value by 7%, with the major drivers being the U.S. inventory writedowns and foreign currency movements. On a current, non-current basis, current inventory decreased to AUD 182 million, reflecting the moderated sales expectations in Treasury Americas and Treasury Collective. Non-current inventory increased AUD 7 million, driven by the transfer of inventory from current and partly offset by inventory writedowns. In Australia, we made good progress towards our focus on rebalancing supply and demand. In the U.S., as mentioned earlier, we are taking action to rebalance our inventory position, starting with vintage 2026, where we will fallow a number of North Coast vineyards to reduce grape intake. Turning now to cash flow and net debt. Net operating cash flow before interest, tax, and material items was AUD 535.3 million for the period, a decrease of AUD 34.7 million on the prior comparative period, driven by the lower top line, while cash conversion was 81.4%, reflecting cash costs associated with intake and production from the FY 2026 vintages. Capital expenditure was AUD 113.4 million and included maintenance and replacement CapEx of AUD 70.7 million and growth CapEx of AUD 42.7 million. This growth CapEx related to the redevelopment of the Beaulieu Vineyard Cellar Door in Napa, with that project now complete and the new site opening in July. FY 2027 CapEx will be reduced to approximately AUD 75 million, reflecting the elevated focus on cash preservation to support deleveraging. Finally, turning to capital management. Leverage was 2.8x, slightly ahead of the 2.9x we communicated at the investor day, and this is expected to be the peak ahead of a return to target below 2x by the end of FY 2028. We have a deliberate and disciplined approach to deleveraging, including an elevated focus on near-term cost control and working capital initiatives to support free cash flow generation, including accelerating TWE ASCENT benefits where possible. Expected proceeds from asset rationalization, namely brand and supply assets, where several sale processes are currently underway. The ongoing rightsizing of CapEx, with this reduction supported by a well-invested asset base and reduced asset footprint, and continued suspension of dividends with the board to consider resumption as leverage trends towards our target level. Our liquidity position remains healthy, with available funds of AUD 1.3 billion at June and a well-diversified debt maturity profile. As previously communicated, AUD 300 million in additional commitments was established in March with strong ongoing support from our lending group. Thank you, and I will now hand back to Sam to talk about the FY 2027 outlook. Thanks, Justin. As we transition to the regional operating model, the performance of our power brands and regional heroes gives us great confidence in the future of our portfolio. Currently, these represent around 70% of global NSR and 80% of gross profit, and pleasingly, each of the portfolios delivered depletions growth in FY 2026. From FY 2028, we will be increasing our investment behind the portfolio in line with the overall uplift to group brand investment focused on unlocking the full potential of these brands. As you can see on the slide, our non-priority portfolio declined 14%, most of which was driven by commercial brands decline, showing the divergent trends within the portfolio. We will continue to carefully manage the contribution of these brands to meet customer commitments and maintain production scale in line with our ASCENT strategy. Turning now to our group and regional outlooks. In FY 2027, strong depletions-led momentum for our power brands and regional heroes will be offset by the continued progression of channel health initiatives. As I have mentioned at the start, we reiterate our expectation for group EBITS to be at least equivalent to FY 2026, with top-line growth for Penfolds and the benefits of Project ASCENT to be offset by declines for non-priority brands. For non-priority brands, distributor inventory rebalancing, and the sell-through of remaining nil margin RNDC inventory. While EBITS appear flat due to progression of customer inventory rebalancing, underlying performance shows substantial improvement year on year. For Greater China, FY 2027 EBITS is expected to be in the range of AUD 280 million- AUD 310 million, with continued depletion strength for Penfolds to drive growth as customer inventory rebalancing is completed. EBITS will be second half weighted, primarily due to the phasing of shipments for Bin 407. For emerging markets, EBITS is expected to be in the range of AUD 95 million- AUD 115 million, with Penfolds continuing to be the driver of regional performance. As noted on the slide, our ongoing vigilance may see some further transition of shipments from emerging markets to Greater China, which we have accounted for in the outlook ranges. In the Americas, EBITS is expected to be approximately AUD 50 million, reflecting the impact of customer inventory rebalancing, sell-through of remaining RNDC inventory at nil margin, and further premium portfolio declines. EBITS will also be second half weighted, driven by the phasing of customer inventory rebalancing and the sell-through of RNDC inventory. In ANZ and Europe, FY 2027 EBITS is expected to be in the range of AUD 100 million- AUD 120 million, with top-line growth for Penfolds and ASCENT savings driving EBITS growth. Our ASCENT initiatives are intended to progressively improve the quality and sustainability of earnings over time, while strengthening our balance sheet and enhancing returns. We thought it would be worth recapping the timeline we shared at our investor day. From FY 2028, with customer inventory having been rebalanced, we expect to return to depletions-led revenue growth driven by our power brands and regional heroes, as we continue to manage declines in non-priority brands. Over time, we see a strong pathway to improving profitability, with EBITS margin progressing to our long-term target of 25% plus, driven by the top-line growth and supported by ASCENT cost savings, hitting full run rate by FY 2029. Additionally, the work we are doing across our supply chain in both Australia and the U.S. will support margin delivery over that time horizon. We also have an elevated focus on ensuring our ROCE returns to an appropriate level, with earnings growth supported by a more disciplined capital allocation focus. In summary, FY 2026 was a year of decisive action and significant change. We enter FY 2027 with improved momentum and clear priorities, which include continuing above-category depletions growth for our power brands and regional heroes through a disciplined focus on execution in-market. Advancing customer inventory rebalancing for completion in FY 2028. Reducing leverage with an elevated focus on cash and working capital. Progressing the TWE ASCENT transformation, and completing the Americas strategic review. Thank you again for joining us today. I will now hand over to the operator to take your questions. Thank you. If you wish to ask a question, please press star one on your telephone and wait for your name to be announced. If you wish to cancel your request, please press star two. If you are on a speakerphone, please pick up the handset to ask your question. Your first question today comes from Michael Simotas with Jefferies. Please go ahead. Morning, everyone, and well done on all the work you have done so far. First question from me is on the FY 2027 outlook. I just want to understand your confidence in delivering group EBIT, at least equivalent to FY 2026. The reason I ask is you have given ranges for each of the divisions. If we look at the bottom end of those ranges, it would imply something quite a bit below the group level. How should we think about what it would take to land within the ranges for the divisions? Thanks, Michael. I might just start this myself and then pass over to Justin just to give you some confidence around the numbers. What really gives me confidence in relation to our outlook is the strength of our underlying business and the depletion momentum that I talked through in the presentation. When we look at the execution focus we have got on these power brands and regional heroes and what we did in H2 in relation to building momentum behind that, I think that confidence comes from the strength of those brands and the work our teams have done around the world to support execution. Really, that is what is underpinning everything. When we look at the ranges, we have talked a little bit about some nuances in relation to the transfer of parallel out of markets and into China, and we have seen a little bit of that this year, and really, really strong China depletions growth. We are getting strong feedback from China that they are feeling that transition. It is giving them real confidence in the work that we are doing to strengthen that distribution network through controlling that parallel. We recognize that this is a bit imperfect. We are still finding areas of concern, and we are taking strong action in relation to that. Some of that range allows us to move volume from one market to another as we take that proactive action. Really, that is what underpins my confidence. I might pass to Justin just to give a sense of the numbers. Yeah. Thanks, Sam, and good morning, Michael. I think it's important we anchor to the expectation that group EBITS will be at least equivalent to FY 2026. That's the guidance, and that's what we are very confident to deliver. On top of the execution momentum that Sam has talked to and the market-facing momentum, the result will be underpinned by the coming through of ASCENT-related benefits of at least AUD 40 million. So we've got good confidence on that being delivered. The ranges we provided are just to help with the new look of the world under the regional model. More so than being definitive. So yeah, as I say, start with the group guidance, and that's exactly where we expect to be at the end of the year. Yep, that makes a lot of sense. Thank you. My second question is relating to the Americas. You're assuming in your outlook a significant decline in the Americas down another about AUD 60 million on the new way of looking at things. The reasons for that are obvious as you work through the inventory. How should we think about more of a mid-cycle earnings number for that Americas business? If I infer from your written down carrying value, it would suggest an earnings number, probably something around the FY 2026 number or even higher. Is that the right way to think about a base that you can then hopefully grow from once you've cleaned up all of the inventory? Yeah, again, I might start, Michael, and then I'll pass to Justin. I think that we've been clear that we're fixing some structural imbalances in the market. We're really taking proactive action as it relates to supply chain initiatives, operating model inventory, and trade inventory. So these things are really proactively being addressed right now, and that's clearly having an impact on that comparable earnings number that you reference. We expect and will continue to update the market as we develop these initiatives, that to improve over time. But right now, there's still a whole lot of work in progress. We're addressing those core issues, and that's what's driving the number that you see. Yeah. Michael, again, just to build. I think you're right. On FY 2027, we expect the headwind from the sell-through of the remaining RNDC stock, the ongoing taking of inventory out of the trade, and then ongoing declines across the premium portfolio led by 19 Crimes. I think from a mid to long-term, that will come back. However, what we talked about a lot at the Investor Day, that COGS imbalance or that COGS drag that comes through because of the structural misalignment, does weigh on the result in the medium term. So, just be careful in terms of how quickly that bounce back happens. That's helpful. Thank you. Your next question comes from Michael Torner with RBC. Please go ahead. Hi, team. I have a question on the Asia ex China depletions data, 18.1% growth. I can see that it's adjusted to exclude the estimated value of depletions contributing to parallel activity from the region. I'd be curious to know what that adjustment number is and how you estimate it, like what the methodology is. Yeah. Thanks, Michael. It's Justin here. It's approximately 10 percentage points of growth. There's a comment around the China depletions growth being approximately half contributed to the parallel capture and an adjustment for Southeast Asia. I think the way the team's looked at that, particularly from a China point of view, where we can cross-reference it to anecdotal feedback from customers, analysis of the e-commerce data, and what we can see coming through cross-border e-commerce. There's been a bit of triangulation work to try to quantify that on the China side, and that has then been applied back to the Southeast Asia side. That's essentially how we've done it. Okay, thanks. I thought I might ask Michael's question earlier just a slightly different way. I am curious how big the margin headwind from the RNDC inventory that you repurchased in California was to half 2026, just to help us inform that margin drag into FY 2027 from the remaining 60%, then we can get an understanding of what a true underlying margin might be in FY 2028. Yeah, sorry, Michael. I think at a total Americas level, the impact is about four percentage points of margin. I think we have communicated previously that that buyback of inventory for luxury was approximately AUD 100 million, at full sales value. We have noted today that 40% approximately has come through in FY 2026, with the remaining 60% in FY 2027. I think if you just apply a standard luxury margin to that, you will work down the EBITS impact. Okay. Thanks very much. Your next question comes from Shaun Cousins with UBS. Please go ahead. Thanks. Good morning, Sam and Justin. Maybe just my first question just around Penfolds and the halting of Bin 407 shipments. Just keen to understand why now? What does it reflect about, I guess, the level of gray market supply of that product and maybe current pricing trends and the risk that you might have to do this with other product ranges? Thanks. Sure. Hi, Shaun. Thanks. Yeah, look, we have taken, again, some decisive action as it relates to 407. We saw some trade practices in China with 407. That it was being used as a kind of a commercial lever, to help migrate some of that cross-border trade into that domestic distributor market. It was having an impact on pricing. We weren't getting the pricing that we wanted. So again, in order to bring that back into control, to preserve the strength of the brand and make sure that that positioning stays intact, that we would take a strong action and reduce shipments again to show everyone in the trade across the region how serious we are in relation to taking control of our route to market in China and in those parallel flows. So, it's been well-received. I would say that pricing of 407 has stabilized. We're starting to see some price rises back to where we would like it to be in July. That's really what we're doing. It's really the strength of conviction we have around taking control of our brand in our critical market of China. Great. My second question is just around the Americas and depletion. So the growth. Can you just talk a bit about the fourth quarter 2026 depletion trends in the U.S.? It seems to have improved. And really how much of that is TWE benefiting from an improving luxury market over there, or is TWE out-executing the market and hence regaining some of the market share that's been lost in some of that improvement in the back end of fiscal 2026, please? Yeah. No. Look, thanks, Shaun. I think that pleasingly we have seen the market return to flat to slight growth in Q4, particularly the above AUD 20 segment that we so proactively participate in. There's no doubt some of that momentum is starting to be felt. I've started to talk about execution really since I began, and focusing on really strong brand plans, really strong in-market execution, depletions being our core measure, brand health being our core measures. All of those things have really changed the focus of our business onto that in-store, in-market, in-channel execution. And no doubt, that is having an impact. So I think it's a bit of both, but really pleasing second half performance. And our goal is to take that all the way through 2027 and beyond, based on the strength of brands that we all know we've always had. Great. Fantastic. Thanks, Sam. Your next question comes from Craig Woolford with MST Marquee. Please go ahead. Morning, Sam and Justin. I think we're all trying to just wrestle with the implications of the de-stocking on earnings, particularly for the Americas. But just trying to understand, when you go through the de-stocking, it's both Penfolds and the Americas, are there any other costs other than the cost of goods sold? Are there any costs that are avoided? Trying to think through the loss either because of de-stocking. Is it just the gross profit or is there any other cost items that would be impacted by the process of de-stocking? Yeah, Craig, it's Justin here. I think the answer is no. It's really just the lost shipment. AMP is there to drive depletions in the market. You might get a little bit of tidy up here and there, but by and large, the cost just comes through the shipments line. I'd add, Craig, that we've always had two areas of focus here to drive, if you like, the correction of our inventory. One of those is reducing shipments. Going back to the previous comment, the second is that focus on driving faster depletions, because that eats away at that inventory and normalizes it faster. So we've got two areas of focus in doing that. Principally, driving depletions on the back of brand health and then reducing shipments in a very controlled way so we can bring us back to the levels that we've articulated in the presentation. Okay. That makes sense. Just a question about Bin 407 issue that you've raised. More broadly, is the phasing of releases going to be much different to what it has been historically? The Bin 407 seems more of a transitory issue. The reason I'm asking this, just trying to understand what the typical skew of earnings is going to be between the first half and the second half, which will largely depend on how you choose to release the premium wines. Yeah. Actually, wine. No. Look, I don't think we plan on any change. The release dates, since we're right in the middle of it at the moment, are working well for us. It's a date in everyone's diary. We've got huge activation behind it. Use this as an opportunity just to say how excited I am about this year, our 75th year of Penfolds, and some of the ratings that we got for the wines, particularly white wines, were extraordinary. So, we're excited. The trade waits for this date. We know consumers and customers all around the world are lined up to it, so no change as far as I'm concerned going forward. Bin 407 will shift back once you've sort of recalibrated things. Yes. Correct. Yep. Got it. Thank you. Your next question comes from Tom Kierath with Barrenjoey. Please go ahead. Morning, guys. Just on the 200,000 cases of de-stocking you did with Penfolds, can you give us a bit of a guide on how much revenue that impact on the revenues and which region that de-stocking occurred in, just so we can kind of, I guess, get a bit of a underlying base for the second half? Look, Tom, I think in relation to which region, that's kind of universal across China is where that's been reduced. It's kind of also a bit linear across the whole portfolio. We really focused on making sure that the whole portfolio was reduced in line with where we thought that we had too much stock or too much in the market. So, no nuance really there. From an NSR perspective, it's not something that we would share. We've shared that there was 400,000 cases of stock that we needed to take out of the market to get back to our, what we would consider optimal levels. We're halfway through that. The second half will be done in this fiscal year. Okay, cool. Secondly, how long will this strategic review take in Americas? The business kind of, I think a few years ago, you're saying it's going to make AUD 400 million, now it's going to make AUD 50. I assume while there's a strategic review going on, it's hard to motivate the troops. So can you give us a bit of a timeline as to when you expect to have some decisions on the future of that business? Yeah. Yeah, look, I think as fast as possible. We've started the review. I've been pleased actually with how much progress we've made. We've really understood what we need to do in the supply chain and those initiatives we've outlined here. Again, we've taken some significant inventory provisions. We shared those on Monday. Again, they help us rightsize that mismatch that we've got across our supply and demand organizations. We've appointed some advisors to look at further options as they relate to brands and assets across the market. We commit to come back to you as they progress. There's nothing more to update you in relation to that at the moment, except to say that we've been pleased with the response and we expect to give some material updates, in the near term. What keeps everyone excited, just picking up on one of your points, is the momentum that we are building in the market around brands and execution and innovation. That is exciting, and we look at what we are doing with DAOU and Frank Family and some of the innovations that we put into the market in the second half that help support that depletion growth, really promising. We are starting to see share gains on the back of that execution, and that is what excites our teams in those markets. Again, we have got great plans for 2027 that give us great confidence that we can continue that momentum. Great. Thanks, Sam. Your next question comes from Peter Marks with Goldman Sachs. Please go ahead. Oh, hey, guys. I just wanted to talk about China again. Can I just clarify with the depletions number? I think it is about 35%, and you are saying about half of that is driven by diversion of parallel imports. So can we call it 17% underlying? I guess where I am going with that, do you think you can sustain that level of depletion growth into FY 2027? Because then once you get to FY 2028, if you can do that level of depletions, it implies a massive year for Penfolds in FY 2028 if your sales catches up to where your depletions are. Does that make sense? Yeah. I think I've talked very positively about Penfolds almost since I began, and the strength of the brand, and it transcends wine really. It's a luxury brand. During our investor day, we outlined areas of opportunity for Penfolds as it relates to Baijiu, recruiting into meal occasion. What we've got for white wine, innovation, gifting. There's still, in my view, huge runway, in China, in the rest of emerging Asia, in Australia, and in Europe, the U.S. So, the runway for Penfolds is long, and the portfolio opportunities we've got are also long. I'm not about to give guidance in relation to depletions, but we've got great confidence, in the growth areas, the growth opportunities for Penfolds and the organization is aligned behind all of them, whether that's the distribution expansion opportunities in China, whether it's innovation, whether it's white wine. The brand's still got huge opportunity. Okay. That's great. My second one just on the Americas drivers into FY 2028. Just so I can get my thinking clear. It sounds like RNDC should be done in FY 2027, so that margin impact should roll out. You'll still have some inventory rebalancing, depressing sales. But that will roll out in FY 2028. But then FY 2028 has the COGS per case headwind. I'm just trying to wrap my head around the moving parts there. Is FY 2028 a year of earnings growth for the Americas business, or is the COGS per case headwind going to offset those tailwinds coming out from RNDC and destocking in 2027? Yeah. We've been quite transparent on all of those things, the zero margin coming back in from the returned goods. Look, the great news for us is that we've navigated a pretty tricky situation with RNDC really well. We've managed to transition into our new distributor pretty seamlessly. Those businesses and those partners doing really well for us. We've taken stock back and offset that, got settlement for various disputes, and now we've got really very small exposure. So that's great news. I did talk about some of those structural mismatches, the imbalance that we've got. We're working on those things now, and the best guidance I can give is that we do expect our earnings profile to improve over the medium term. But we will come back with much more material updates, as we develop those strategic options, as we've got further into understanding what value they might bring to us, so that we can reliably inform you. JP, have you got anything to add? Yeah, Peter, while we're not giving long-term guidance today, I think you're thinking about it the right way in terms of the progressive rundown of the 300,000s. Most of that, or the bulk of that will be done this year with some carryover into half one next year. RNDC is a one-time item this year. So we do see those things being corrected, and we'll eventually get that business into a depletions-led top-line growth position, which should give us revenue growth going forward through 2028. And that should translate to better earnings. Thanks, Sam. Thanks, guys. Your next question comes from Bryan Raymond with JPMorgan. Please go ahead. Good morning. My first one is just actually just on the ASCENT benefits. Just wanted to make sure we have them allocated properly, the AUD 40 million in 2027. I think it was called out in the ANZ in Europe division. Is that where most of it's flowing, or is there a bit of a mix across the four new divisions? Yeah. Hi, Bryan. It's Justin here. The benefits flow across all divisions, maybe with the exception of Greater China, where we'll be investing in the ongoing growth in that region. As I say, the AUD 40 million is going to come from all divisions, all regions. It probably weights more to where the teams are bigger at the moment, so Australia and the U.S. Right. Okay. Just maybe on inventory. Obviously, the write-down in the U.S. that you called out earlier this week is contributing to that coming down a bit year-on-year. Just wanting to understand, let's call it volume or underlying inventory, and that path from 2.8x- 2x leverage. Just interested as to whether we think underlying inventory has peaked, and it's now just a matter of that coming down. Or do you have some more, let's call it historical vintages flowing through that's going to add to that we need to just be mindful of in that path down to 2x leverage? Thanks. Yeah. I think we touched on this a little bit at the investor day, and certainly from where we're sitting at the moment. FY 2027 will still be another modest increase in working capital, and that's really talking to the speed at which the supply transformations, both in Australia and the U.S., can take hold. So, whilst not significant, we do expect to see another slight build in inventory, and that's why that pathway to leveraging, yes, we're confident we're at the peak at 2.8x and we'll go down from here. That will accelerate in terms of FY 2027 to FY 2028. Just as a follow-up to that, should we just assume a sort of linear profile, or would it be a bit more of a reduction in inventory in 2028 year-on-year versus 2027 year-on-year? Probably more the latter. Yeah. Okay. Perfect. Thank you. Your next question comes from Ben Gilbert with Jarden. Please go ahead. Good morning, team. Just the first one from me. Just in terms of all the work you're doing around inventory realignment, appreciate it's nine months away, but do you think it's going to give you scope to take some price on next year's release, particularly in Penfolds? In that light, do you think you can grow revenue into FY 2027? Yeah. Hi, Ben. I think we have been disciplined in relation to pricing in the past, and usually as a result of how we are trying to position the brand and the elasticity in market. Clearly, some of the cost of living pressures of recent have made that more difficult. I think very pleasingly in China, we have seen Moutai and Wuliangye, the number one and two Baijiu players, take price. That is kind of decompressed the market a little bit, in China. As we come into future releases, we will certainly be looking at the role price can play in those releases and how we can position our brands in those markets, in relation to any price movements that have been received during the year. It is certainly part of our thinking. We certainly think that pricing is important to maintain the positioning of our brand, and it will be considered in future years, as it normally would. Do you think you could grow revenue into FY 2027 then if you were able to get some price back in on the next vintage? I think the goal for us across the business is to grow revenue. We have got some structural things we are dealing with, particularly as it relates to parallel and inventory and other things. Yeah, we do see that price will be a lever for us across all of the businesses, as we look at year-on-year planning processes. Yeah. I do think price can be a lever. Great. Just a final one from me. Just on your white versus red mix in Penfolds. Obviously, white is pretty mature at the moment, pretty materially below sort of 10% NSR. How quickly can you ramp that up with the view? Obviously, you can probably release a little bit more quickly. Have you been out there trying to secure more supply? I am just trying to get a picture for how materially you could ramp that up, particularly given the demand we are seeing in Asia and China specifically for it at the moment. Yeah, it is exciting. I think just about all markets around the world, we are seeing some real momentum in white wine, through female consumption, through refreshment occasions. So Matua doing really well, and early signs our Penfolds white wine collection is doing really well, as I mentioned in the presentation. Actually, white wine in China also showing some real growth potential. So that is a big opportunity given the strength of the brand. I do think it is going to play a bigger role. We have not given guidance in relation to that mix impact yet, but at a headline level, we see it as being a significant growth driver. Is there much decent juice for grapes around that you can actually get in the Chardonnays and those sorts of things, or is this a five-year type thing where you have actually got to build it out? Yeah. We have looked at that modeling, Ben, and I think we feel very confident that we have got appropriate supply that underpins our ambition. Fantastic. Appreciate it. Your next question comes from Caleb Wheatley with Macquarie. Please go ahead. Morning, Sam and Justin. Just wanted to come back to the deflation strength in Penfolds, and particularly in China. You sort of alluded to it a little bit throughout some of the prior questions. But even taking out sort of half of that growth that is relating to parallel importing, the headline number is still really, really strong. And it seems like most of the sort of industry level or anecdotal feedback coming out of China is still relatively weak. And I know you mentioned yourself, there are still some kind of areas of concern. Just, yeah, sort of wondering what is sort of happening more specifically on the Penfolds brand and what is really driving what is a, yeah, seemingly really strong deflation number there, given those industry anecdotes? Yeah. No, thanks for the question. Look, I think, again, we went into quite a lot of detail during the Investor Day on China and really where the opportunities exist, and they are multiple. Some of that is the migration of parallel that we have talked about, but actually in the market, we look at province and sub-provincial distribution opportunities. They are really significant. We look at distributor expansion into third, fourth, fifth-tier cities. We look at portfolio and we say, look, there are lots of opportunities to fill distribution gaps across the portfolio. You look at white wine, festive occasions like Mid-Autumn and Chinese New Year, exceptionally strong, the release. So, add to that kind of migration from Baijiu, and we see some of that happening, particularly in restaurants. And moderation trends really favoring the alcohol strength that sits inside of our wine. Finally, again, I keep talking about Penfolds, the brand that transcends wine. This is a luxury brand in China, and that status continues to drive growth. All of that, along with a recovering wine category, give us great confidence that we can continue through the enormous market of China to drive growth. That is what underpins our assumptions. Okay, great. Then just moving forward on the Penfolds side, but I guess more broadly across the brands, just as you shift to the geographic segmentation, just wondering what kind of disclosure we can expect around those major brands. Just conscious the market clearly focuses quite strongly on Penfolds, but will increasingly focus on the three power brands that you are calling out. Yeah. Penfolds is a key driver globally. Clearly, we can see on the back of the strength of the equity of the brand that there is huge opportunities in all markets globally. I have talked about India. I cannot wait to get to India and start to explore the opportunities that exist in that really interesting market. It is nascent at the moment, but has lots of opportunities. Look, I think Matua is an interesting one. We are already getting lots of feedback from Matua in China and the opportunity that exists there, and we will look to spread that more broadly around the world. Early days on DAOU, but we have had DAOU up in China and the emerging markets of Southeast Asia. Early signs are positive, but we have got more work to do in relation to those opportunities. So, it is predominantly led by Penfolds with Matua and DAOU having opportunities. Look, when we look at some of those regional heroes, we also see opportunities for brands like Squealing Pig in the U.K. or Pepperjack in other markets around the world. So, we will continue to look at them in the context of those brand priorities and see whether or not opportunities exist in markets outside of their home markets. Caleb, it's Justin here. Just to build on Sam's response, in terms of your question about what to expect going forward from a disclosure point of view. Geographic segments is obviously how we're going to look at this business going forward, and that will be our primary way of reporting. We're working through the other stuff that sits around that. At a minimum, we would expect to give insights, pretty strong insights on our power brands as we move forward. But as I would emphasize, we are still working through some of that. Okay. That is clear. Thank you very much. Your next question comes from Richard Barwick with CLSA. Please go ahead. Thank you. Good morning, guys. Can I just pick up a couple of points and draw them together? I think on one of your slides, Justin, you were talking about the Project ASCENT being cash flow positive post-divestments. I guess my first question really is, should we be expecting more in the way of one-offs and write-downs? Because right now you are talking about the cash impact being up to a AUD -195 million. Therefore, the divestments have got to be something greater than that. Can I just clarify those points, please? Yeah. Hi, Richard. Your thinking's right. I am just trying to find the slide. I think you asked two questions there in terms of can you expect more one-time items on top of what we have disclosed today. I think the work around the Treasury Americas strategic review is still ongoing. We have made good progress to date with what we have been able to do and the decisive actions we have been able to take around supply. Ultimately, we are continuing to do that work. In terms of what's outlaid as the expected cash costs on the remaining elements of the ASCENT program, they are our estimate of today. I think, correct. You take the sum of those, and if we are saying cash positive, it means the divestment side is expected to be greater, and that's correct. I would also just draw back then into the leverage comments, and we emphasized this at the Investor Day as well. We see a pathway to 2x leverage or lower without those divestments in the plan. A couple of things there just to cover off. Sorry, you are saying you can get to 2x without divestments? Correct. That's right. That's consistent with what we are committed to or noted at the Investor Day. That's what I thought. But the wording today, it actually made me think the opposite, that the 2x was reliant on or included divestments. No, apologies if that's been the way it's been interpreted. That's certainly not the case. The divestments are still part of our capital management plan, and we've been pretty pleased with the response on what we've tried to take to market to date. But we still see a pathway to 2x or less without those divestments. Okay. Thank you. Just to round that off, you're saying that the several divestment processes underway. In terms of the, I guess, the cash contribution, you're flagging there could be brands, but also productive assets. Should we be expecting most of the cash to be coming from brand divestments or from the productive assets? Oh, it's a mix. It's a mix, Richard. Without getting into too much detail now, there's a number of assets we've identified across the hard assets vineyards, and then production assets and also brands, and we're working through a number of them at the moment. Yeah. Yeah, Richard, I think- Okay. This, we'll come back to the market, I would suspect before the end of the year with an update on that, and give some progress around all of the actions we're taking. I think it's worthwhile in relation to that broader leverage goal and how we're going to get there is a real significant focus on working capital, and trying to ensure that through all of that initiative, we extract cash that we use to obviously drive down our leverage. Really that's what underpins our confidence that we can get there without divestments. The further we get into that, the more confident we become. Yep. Okay. That's really helpful. Thank you. Your next question comes from Phil Kimber with E&P Capital. Please go ahead. Hi, guys. Just a question around the new divisions. I do not know if this is the right way to look at it, but if I look at Greater China in the second half, EBITS has jumped about AUD 30 million, and I look at emerging markets in the second half and EBITS has dropped AUD 23 million. It looks like a lot of the EBITS that dropped is because you have switched, you have cracked down on the parallel importing, so that effectively shifts profits out of emerging markets into Greater China. I look at your guidance, and I get the Greater China one, AUD 280 million- AUD 310 million, and you look at the second half and then you think about the 407 issue and that, fair enough. But I look at emerging markets and I go, you did under AUD 40 million in the second half, and you are saying your full year is going to be, let us call it AUD 100 million. What is changing there? Am I thinking about it wrong and you cannot just annualize the second half? I just wanted to understand that a bit better. Thanks. In particular, around emerging markets. Yeah. Good morning, Phil. Hi. I do not think annualizing the second half is the right way to look at it. It has been a bit more nuanced as we have worked into it. I think the other comment to make is within those emerging markets, there are a number of strong domestic markets that still continue to grow and present opportunities. So you have got a bit of a balance of domestic growth, potentially, some trade out of parallel, but that gives us the range we have presented today. Okay, thanks. If I do the same thing in the ANZ and Europe business, again, should we assume that to get to the AUD 100 million- AUD 120 million, when you look at the second half run rate, you need a lot of those cost savings actually will end up falling in that ANZ business, that will be the bulk of the cost savings, because I just could not get it to reconcile otherwise. Yeah, again, I think you are looking at it pretty well there. A lot of the ASCENT savings will be weighted to ANZ in Europe, and that drives a lot of the uptick in that P&L. I think also, as we communicated today, we see ongoing strong depletions growth for Penfolds, and that will play a part. We have 5% experience this year. We will expect growth next year and improved mix supporting that. So there is a couple of drivers, but ASCENT will be one of the keys there. Awesome. Thank you. Your next question comes from Sam Teeger with Citi. Please go ahead. Hi, Sam. Hi, Justin. Well done on the progress you have made turning this company around to date. I wanted to ask around what is the price range you are targeting for Bin 407 in China? Based on the improvements you are seeing in Bin 407 pricing over the current quarter, what is the potential that this shipment pause might end earlier? Following on from that, to what extent are your global Penfolds distributors seeing increased demand for Bin 407 right now given the China shipment pause? I'm just hoping I'm understanding this question right. I think that what we're looking for in China, we've been trading about 10% below where we would like. Your target price is sort of north by about 10%, is what we're targeting from a portfolio perspective. Again, some of these actions are all in service of ensuring that we provide the conditions that will allow us to deliver that, and that we organize our route to market across the region, in a way that brings control back into that pricing and how the product flows. Really, this is a complicated system and it's a little bit imperfect, but that's kind of what we're looking to achieve through all of these programs. That's where we would like it positioned from a brand perspective. Across the rest of pricing as it relates to Penfolds, we think about that with each market and then in the context of how those markets can interrelate and make sure that we've got a coordinated approach that we plan for as we do our brand plans every year. As I mentioned earlier, we're always looking to take price to support that positioning and we look at that when we develop the brand plan. We'll continue to do that going forward. I hope that answers the question. Yeah. Thanks. Given the growth we are seeing in Chinese wines, could you please give us an update around the Ningxia Stone & Moon winery? When might we see increased products coming from here? Yeah. We continue to be excited about our investment in Ningxia. We've now looked at developing grapes that we can put into our China-sourced Penfolds products, and we've had a lot of exchanges with Chinese winemakers and our winemakers really developing capability that would allow some of that grape to go into Penfolds. The Stone & Moon brand continues to be sourced from there, and again, we continue to execute that in the market. But the opportunity for us is to start to develop a Chinese-sourced grape variety for Penfolds. I think that we're progressing well as it relates to that investment. I would also say that we have a strong relationship with the government there that continues to support us as well. So, that investment is playing a huge role in how we develop the overall industry in China, and I'm excited about that. Great. Thank you. Your next question comes from Mark Southwell-Keely with Select Equities. Please go ahead. Hey, guys. Thanks for taking my call. I have two questions. Firstly, I am interested, Sam, perhaps, in terms of what learnings you take from the wholesale pricing of Grange at the moment. You have reduced allocations of Grange. You have also spent or invested significantly in the global Grange campaign, yet wholesale pricing continues to deteriorate and be soft. Just wondering what your learnings are from that. I think all of the work we are doing on Grange is to continue to support the role that it plays at a brand level, which is the pinnacle. This is what everyone aspires to buy. Again, the limitation of what we make is all about bringing more scarcity into that equation, making it sought after globally. I think the response to that has been really fantastic. The campaign, again, just reinforcing that aspirational, inspirational positioning. I feel like we are on the track to ensuring and protecting the critical role that it plays inside the portfolio. I am conscious at release that there is often lots of noise around wholesale pricing. In fact, my feedback from the release has been that some of that noise has been significantly reduced coming into this release, and the pricing is more stable than it has been in the past. Again, another anecdotal data point to say all of these actions are really supporting the role that we want Grange to play. The learnings are that the actions that we are taking are really strengthening the propositioning and its positioning. I am quite pleased. My second question is in relation to the pause on the shipments of Bin 407. I am just wondering if you can explain the logic or the consistency of the logic, perhaps, in terms of, on the one hand, you are saying to the trade that you are necessarily temporarily suspending the shipment of the product for a three-month period. But on the other hand, you are telling the market essentially that you are guaranteeing a certain product volume over a 12-month period. Can you just maybe reconcile those two logics? I think what we had seen happening at a market level with 407 was concerning. I would say it was being used as a lever for trading and facilitation of trading. We have just sent a message by suspension that that is not on, that we will not put up with that we cannot have such a critical component of our Penfolds brand being used to facilitate trading activities. It is the best way I can describe it. If that continues, specific customers will be targeted, and they will not have access to 407 or other parts of the brand. It is really just a signal to the market about the conviction we have got of bringing our route to market as it relates to Penfolds back into control and the role that we need it to play in the development and support for the brand. I think that message has been received. It has not been done before. It is a strong message, and it says, "If you do not adhere to the conditions that you sign up to when you become a partner of ours, there are ramifications." Longer term, we have set that standard, and we have said, "Right, we can go back to normal trading as long as you adhere to those conditions," and that is why the allocation has remained the same. That is the psychology of it. It is really about sending a strong message on the back of trading activities to our partners in our distribution chain. Does that make sense? Not really, but thank you. Okay. Your next question comes from Michael Simotas with Jefferies. Please go ahead. Hi. Thanks for taking another one. Just an accounting question, if I can, relating to the impairments and write-downs that were announced earlier in the week. There should be a P&L tailwind from less depreciation on physical assets, less lease depreciation on the written-down right of use assets, and then maybe some implications from written-down inventory as well. Appreciate that a lot of that will be tied to COGS, but just want to understand how that will flow through the P&L in terms of phasing and also, whether there will be a little bit of a cash versus earnings mismatch as that starts to come through, presumably not for a year or two. Yeah. Hi, Michael. I think when you said accounting query, that was coming straight to me. Right. You are right, there will be some lease and depreciation savings as a result of the write-downs we made or announced on Monday. That flows 100% into our vintage costing and is captured as part of our vintage 26 COGS process. In a normal year, that would take two to three years to flow through the P&L. Albeit, we are working through some elevated levels of inventory, so that flow-through will probably take a little bit longer. So, there is a benefit as a result, but it does take time to realize, and I think that's probably the key point. Remind me, what was the second part of your question on the inventory? That's helpful. Thank you. By the time we get out there, as the benefit comes through the P&L, will cash match it or will there be a bit of a cash shortfall given, even if you look at something like lease, your cash outflow might be bigger than what you're taking through the P&L? I'm not sure I understand fully, Michael. Let us come back to you on that one, if that's okay. Okay. All right, we'll follow up later. Thank you. Yep. Your next question comes from Bryan Raymond with JPMorgan. Please go ahead. Thanks for taking a follow-up. Just another one, I think, Justin, just following up on an answer you made earlier in the call, to be cautious around the bounce back in the U.S. from the AUD 50 million base in 2027. We've gone through a number of times a lot of the short-term impacts that are driving the number down to that level. Given how low it is, I just want to understand if there's something I'm missing even in 2028 and beyond that would not make it bounce back a bit more quickly. It just seems like such a low baseline. Is there something out there that we need to be cognizant of that's going to stop that recovery to a more normalized level of EBITS in the Americas? Thanks. Yeah. Hi, Bryan. When we get out of this year, we do expect revenue to grow, but the key drag is the structural misalignment and what that does to our COGS line. I think also as we go through the next few years, we do have a bit of an ongoing portfolio transition as we pivot away from the non-core brands, and there's a bit of decline on those into the power and the regional heroes. So they're the only two core lets, I think, that give a bit of pause on how quickly to expect it to get back. Okay. Just a final one, if I can. Just on the dividend coming back, it's obviously suspended for now. If you get to 2x leverage with that, is that kind of a benchmark that you'd be looking at to reinitiate the deal for the board to decide to bring the dividend back? Yeah. I think that is certainly when we will start having the discussions with the board about an appropriate time, depends on how everything looks going forward. Our goal right now is to focus hard on delivering us back into the target range in that timeframe, and that is when we would expect that conversation to start happening again with the board. Okay. On the previous question, I would just say that some of these structural options that we are looking at have the potential of a material impact on those earnings. We do expect to have earnings progression going forward from this point. Exactly what they look like depend quite materially on some of the outcomes of the discussions we are having inside of those structural options that are being reviewed at the moment. Look, we will commit to come back to you as soon as we start to get more clarity around those, on a very regular basis. Okay. Thanks. There are no further questions at this time. I will now hand back to Sam Fischer for closing remarks. Okay. Thank you very much, everybody. We appreciate your time today, and we appreciate your support in this ongoing journey. We look forward to coming back to you in the near term.